Dr. Carlos Moreno Comments on How Pharmaceutical Companies are Slowing Cancer Research

Dr. Carlos Moreno, faculty member in GMB and CB, has commented in Reuters on how pharmaceutical companies are slowing cancer research.

Read full story>>